IP Library Granted Patent US 11,071,694
Granted Patent B2
US 11,071,694 · App. 15/994,232 · Granted Jul 27, 2021

Topical glycopyrrolate formulations

Inventors: Michael Johnston (Yarraville, AU); Robert James Houlden (Kilsyth, AU)
Assignee: Rose U, LLC
A61K8/0208A61K8/4913A61K9/0014A61K31/40A61K47/10A61K47/32A61Q15/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,071,694
App. No.
15/994,232
Granted
Jul 27, 2021
Kind
B2
Abstract

Individually packaged topical formulations comprising about 0.25 to about 6% w/w of glycopyrrolate for the treatment of hyperhidrosis, wherein said wipe is contained within a pouch resistant to leakage. The formulations may further comprise ethanol, a buffering agent and water. In addition, the formulations may further comprise a polymer system comprising a hydrophobic polymer in combination with a hydrophilic polymer.

Claims (21)

1. A topical formulation comprising:

about 0.25 to about 4% w/w of glycopyrronium bromide,

further comprising ethanol and water in a weight ratio of about 40:60 to about 60:40 and

a citric acid/sodium citrate buffering agent at an amount sufficient to maintain a pH of about 4 to 5.

2. The topical formulation of claim 1 , wherein the buffering agent maintains a pH of 4.5.

3. The topical formulation of claim 1 , wherein ethanol and water are in a weight ratio of about 50:50 to 60:40.

4. The topical formulation of claim 1 , wherein ethanol and water are in a weight ratio of about 60:40.

5. The topical formulation of claim 1 , wherein the ethanol is present in the amount of about 53.7 to about 57.3% w/w.

6. The topical formulation of claim 1 , wherein the buffering agent in the amount of about 0.2 to about 0.5% w/w.

7. The topical formulation of claim 1 , wherein the alcohol is present in the amount of about 53.7 to about 57.3% w/w, the buffering agent is present in the amount of about 0.2 to about 0.5% w/w and the water is added to 100% w/w.

8. The topical formulation of claim 3 , wherein the ethanol is present in the amount of about 53.7 to about 57.3% w/w, the buffering agent is present in the amount of about 0.2 to about 0.5% w/w and the water is added to 100% w/w.

9. The topical formulation of claim 1 , further comprising one or more optional additives selected from humectants, colorants, and perfumes.

10. An individually packaged wipe for the treatment of hyperhidrosis, comprising the topical formulation of claim 1 .

11. The individually packaged wipe of claim 10 , wherein the wipe is made of nonwoven material, paper material, woven material, knitted material, tufted material, stitch-bonded material incorporating binding yarns or filaments, or material felted by wet-milling.

12. The individually packaged wipe of claim 11 , wherein the wipe is made of nonwoven material.

13. The individually packaged wipe of claim 10 , wherein the wipe is folded.

14. The individually packaged wipe of claim 10 , wherein the wipe is contained within a pouch resistant to leakage.

15. The individually packaged wipe of claim 14 , wherein the pouch comprises an inner lining of linear low density polyethylene (LLDPE).

16. The individually packaged wipe of claim 14 , wherein the pouch comprises an inner lining of acrylonitrile-methyl acrylate copolymer (BAREX).

17. A method for alleviating hyperhidrosis in a mammal comprising the topical administration of the topical formulation of claim 1 to an area of the body such that the hyperhidrosis is reduced.

18. A method for alleviating hyperhidrosis in a mammal comprising the topical administration of the wipe of claim 10 to an area of the body such that the hyperhidrosis is reduced.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Feb 20, 2020
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
To: DERMIRA, INC.
Reel/Frame 051882/0260 →
SECURITY INTEREST Recorded Dec 7, 2018
From: DERMIRA, INC.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 047701/0465 →